Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000195161 | SCV000248962 | uncertain significance | not specified | 2015-05-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000226868 | SCV000286037 | benign | Rhabdoid tumor predisposition syndrome 2 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000570901 | SCV000663891 | likely benign | Hereditary cancer-predisposing syndrome | 2018-09-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001561165 | SCV001783709 | likely benign | not provided | 2020-10-20 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001808542 | SCV002056192 | likely benign | Intellectual disability, autosomal dominant 16 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000570901 | SCV002532870 | benign | Hereditary cancer-predisposing syndrome | 2020-12-22 | criteria provided, single submitter | curation | |
Prevention |
RCV003947615 | SCV004762699 | likely benign | SMARCA4-related disorder | 2023-02-08 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |